UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 113

Sortiert nach

Prognostic Value of Pathologic Complete Response After Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Long-Term Analysis of 566 ypCR Patients

International journal of radiation oncology, biology, physics, 2008-09, Vol.72 (1), p.99-107

2008

Link zum Volltext

Verfügbarkeit prüfen

Selecting a TNT Schedule in Locally Advanced Rectal Cancer: Can We Predict Who Actually Benefits?

Cancers, 2023-04, Vol.15 (9), p.2567

2023

Link zum Volltext

Verfügbarkeit prüfen

Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial

The lancet oncology, 2017-03, Vol.18 (3), p.347-356

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Magnetic Resonance Imaging and Histopathological Response to Chemoradiotherapy in Locally Advanced Rectal Cancer

Annals of surgical oncology, 2012-09, Vol.19 (9), p.2842-2852

2012

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Factors for Recurrence and Survival in Anal Cancer: Generating Hypotheses From the Mature Outcomes of the First United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I)

Cancer, 2013-02, Vol.119 (4), p.748-755

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical endpoints in trials of chemoradiation for patients with anal cancer

The lancet oncology, 2017-04, Vol.18 (4), p.e218-e227

2017

Link zum Volltext

Verfügbarkeit prüfen

The concept and use of the neoadjuvant rectal score as a composite endpoint in rectal cancer

The lancet oncology, 2021-07, Vol.22 (7), p.e314-e326

2021

Link zum Volltext

Verfügbarkeit prüfen

Docetaxel, Cisplatin, and Fluorouracil; Docetaxel and Cisplatin; and Epirubicin, Cisplatin, and Fluorouracil As Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial of the Swiss Group for Clinical Cancer Research

Journal of clinical oncology, 2007-08, Vol.25 (22), p.3217-3223

2007

Link zum Volltext

Verfügbarkeit prüfen

Synchronous liver metastases in patients with rectal cancer: can we establish which treatment first?

Therapeutic advances in medical oncology, 2018-01, Vol.10, p.1758835918787993-1758835918787993

2018

Link zum Volltext

Verfügbarkeit prüfen

Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: Evidence of a radiation and chemotherapy dose response

Radiotherapy and oncology, 2006-03, Vol.78 (3), p.236-244

2006

Link zum Volltext

Verfügbarkeit prüfen

Commentary on Latkauskas et al

Colorectal disease, 2012-03, Vol.14 (3), p.299-301

Glynne-Jones, Robert

2012

Link zum Volltext

Verfügbarkeit prüfen

Cetuximab Plus Irinotecan in Heavily Pretreated Metastatic Colorectal Cancer Progressing on Irinotecan: MABEL Study

Journal of clinical oncology, 2008-11, Vol.26 (33), p.5335-5343

2008

Link zum Volltext

Verfügbarkeit prüfen

Reduced incidence of infusion‐related reactions in metastatic colorectal cancer during treatment with cetuximab plus irinotecan with combined corticosteroid and antihistamine premedication

Cancer, 2010-04, Vol.116 (7), p.1827-1837

2010

Link zum Volltext

Verfügbarkeit prüfen

Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control

Annals of oncology, 2014-07, Vol.25 (7), p.1356-1362

2014

Link zum Volltext

Verfügbarkeit prüfen

Bayesian network structure for predicting local tumor recurrence in rectal cancer patients treated with neoadjuvant chemoradiation followed by surgery

Physics and imaging in radiation oncology, 2022-04, Vol.22, p.1-7

2022

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors for recurrence and survival in anal cancer

Cancer, 2013-02, Vol.119 (4), p.748-755

2013

Link zum Volltext

Verfügbarkeit prüfen

Editorial: “Pathologic Complete Response, Total Neoadjuvant Therapy, and the Survival Paradox in Locally Advanced Rectal Cancer,” by Goffredo et al. Without Constancy There is Neither Love, Friendship, Nor Virtue in the World

Annals of surgical oncology, 2024-07

Glynne-Jones, Robert

2024

Link zum Volltext

Verfügbarkeit prüfen

Anal cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up

Radiotherapy and oncology, 2014-06, Vol.111 (3), p.330-339

2014

Link zum Volltext

Verfügbarkeit prüfen

TNT and local recurrence in the RAPIDO trial - untangling the puzzle

Nature reviews. Clinical oncology, 2023-06, Vol.20 (6), p.357-358

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of Hepatic Dysfunction due to Liver Metastases on the Pharmacokinetics of Capecitabine and Its Metabolites

Clinical cancer research, 1999-07, Vol.5 (7), p.1696-1702

1999

Link zum Volltext

Verfügbarkeit prüfen

Diffusion tensor imaging of the anal canal at 3 tesla: Feasibility and reproducibility of anisotropy measures

Journal of magnetic resonance imaging, 2012-04, Vol.35 (4), p.820-826

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(105)

Publikationsform

Artikel
(109)
Buchkapitel
(4)

Sprache

Englisch
(113)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(77)
Life Sciences & Biomedicine
(76)
Humans
(60)
Oncology
(57)
Male
(34)
Female
(33)
Middle Aged
(28)
Aged
(26)
Chemoradiotherapy
(22)
Surgery
(21)
Colorectal Cancer
(19)
Chemotherapy
(18)
Tumors
(18)
Radiology, Nuclear Medicine & Medical Imaging
(17)
Adult
(15)
Cancer
(15)
Radiotherapy
(15)
Rectal Neoplasms - Therapy
(15)
Anal Cancer
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline

Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline

Prognostic Value of Pathologic Complete Response After Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Long-Term Analysis of 566 ypCR Patients

Selecting a TNT Schedule in Locally Advanced Rectal Cancer: Can We Predict Who Actually Benefits?

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial

Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial

Comparison of Magnetic Resonance Imaging and Histopathological Response to Chemoradiotherapy in Locally Advanced Rectal Cancer

Prognostic Factors for Recurrence and Survival in Anal Cancer: Generating Hypotheses From the Mature Outcomes of the First United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I)

Clinical endpoints in trials of chemoradiation for patients with anal cancer

The concept and use of the neoadjuvant rectal score as a composite endpoint in rectal cancer

Docetaxel, Cisplatin, and Fluorouracil; Docetaxel and Cisplatin; and Epirubicin, Cisplatin, and Fluorouracil As Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial of the Swiss Group for Clinical Cancer Research

Synchronous liver metastases in patients with rectal cancer: can we establish which treatment first?

pCR and 2-Year Disease-Free Survival: A Combination of the Two Endpoints as a New Classification for Locally Advanced Rectal Cancer Patients-An Updated Pooled Analysis of Eleven International Randomized Trials

Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: Evidence of a radiation and chemotherapy dose response

Commentary on Latkauskas et al

Cetuximab Plus Irinotecan in Heavily Pretreated Metastatic Colorectal Cancer Progressing on Irinotecan: MABEL Study

Reduced incidence of infusion‐related reactions in metastatic colorectal cancer during treatment with cetuximab plus irinotecan with combined corticosteroid and antihistamine premedication

Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control

Bayesian network structure for predicting local tumor recurrence in rectal cancer patients treated with neoadjuvant chemoradiation followed by surgery

Prognostic factors for recurrence and survival in anal cancer

Editorial: “Pathologic Complete Response, Total Neoadjuvant Therapy, and the Survival Paradox in Locally Advanced Rectal Cancer,” by Goffredo et al. Without Constancy There is Neither Love, Friendship, Nor Virtue in the World

Anal cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up

TNT and local recurrence in the RAPIDO trial - untangling the puzzle

Effect of Hepatic Dysfunction due to Liver Metastases on the Pharmacokinetics of Capecitabine and Its Metabolites

Diffusion tensor imaging of the anal canal at 3 tesla: Feasibility and reproducibility of anisotropy measures

Suchergebnisse filtern